2018
DOI: 10.21037/atm.2018.03.17
|View full text |Cite
|
Sign up to set email alerts
|

Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders

Abstract: The main conclusion of our study is that in people with mental disorders and under treatment with atypical antipsychotic drugs, in order to avoid QT prolongation and reduce the risk of ventricular tachycardia clinicians may recommend aripiprazole, brexpiprazole or olanzapine in licensed doses. Long-term comparative safety needs to be established.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0
2

Year Published

2019
2019
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(29 citation statements)
references
References 87 publications
1
26
0
2
Order By: Relevance
“…Yet, cardiovascular events may occur more frequently when quetiapine is prescribed compared to the majority of other second-generation antipsychotics. [19][20][21] Molecular biological experiences and several case report evaluations strongly indicate a higher risk of QTprolongation when quetiapine is combined with other QT-prolonging drugs, 22,23 for example methadone. 24 Based on the clinical effects of quetiapine mentioned above, we hypothesized that quetiapine can increase the risk of fatal poisonings with opioids, which can be attributed to sedation, respiratory depression, hypotension, and cardiac arrhythmia in case of methadone.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Yet, cardiovascular events may occur more frequently when quetiapine is prescribed compared to the majority of other second-generation antipsychotics. [19][20][21] Molecular biological experiences and several case report evaluations strongly indicate a higher risk of QTprolongation when quetiapine is combined with other QT-prolonging drugs, 22,23 for example methadone. 24 Based on the clinical effects of quetiapine mentioned above, we hypothesized that quetiapine can increase the risk of fatal poisonings with opioids, which can be attributed to sedation, respiratory depression, hypotension, and cardiac arrhythmia in case of methadone.…”
Section: Introductionmentioning
confidence: 99%
“…QT prolongation, which may be observed as syncope are primarily seen in overdose. Yet, cardiovascular events may occur more frequently when quetiapine is prescribed compared to the majority of other second‐generation antipsychotics 19‐21 . Molecular biological experiences and several case report evaluations strongly indicate a higher risk of QTprolongation when quetiapine is combined with other QT‐prolonging drugs, 22,23 for example methadone 24 …”
Section: Introductionmentioning
confidence: 99%
“…L'olanzapine semble un traitement de choix du fait de son moindre risque sur le plan cardiologique [9][10][11], mais expose à une prise de poids importante. L'aripiprazole pourrait aussi être privilégié pour la même raison [11,12], mais nous n'avons pas retrouvé d'étude où il était associé à la lévothyroxine pour le traitement de troubles psychotiques en lien avec une hypothyroïdie. L'arrêt des traitements psychotropes pourra être envisagé une fois le bilan thyroïdien stabilisé et les symptômes psychiatriques contrôlés.…”
Section: Discussionunclassified
“…It is well known that quetiapine prolongs the QT interval in a dose-dependent manner [23]. Because DDIs that increase quetiapine's plasma concentration, such as those occurring with other CYP3A substrates like amlodipine and sertraline [23,24], can mimic higher doses of quetiapine, it is likely that they cause or contribute to the associated risk for QT interval prolongation. Two case reports from the literature of CYP3A4-mediated DDIs involving quetiapine resulted in TdP.…”
Section: Quetiapine: Interactions and Implicationsmentioning
confidence: 99%